Oral Prostacyclins in the Treatment of PAH
When is it appropriate to consider oral prostacyclins in the PAH treatment regimen? A panel of PAH experts discusses the use of newer therapies which target the prostacyclin pathway, such as oral treprostinil and oral selexipag, and the potential role of these drugs alone or in combination with background PAH therapies. Moderated by Richard Channick, MD. Discussants: Lewis Rubin, MD, Vallerie McLaughlin, MD, and Rajan Saggar, MD.